a<p>Not all samples from all time points were tested due to assay failure, missed visits or volunteer withdrawal.</p>b<p>A volunteer is defined as a responder if they score positive to any pool.</p>c<p>One placebo recipient had a positive ENV ELISPOT at baseline; otherwise all tests for placebo recipients were negative (data not shown in table).</p
<p>Gray dots: response below the cut-off to any of the 6 peptide pools; red dots: response above the...
Ex vivo functional immunoassays such as ELISpot and intracellular cytokine staining (ICS) by flow cy...
<p>HIV-specific IFN-γ ELISpot responses two weeks after the first (upper panels) and second (lower p...
<p>At 2 weeks post final immunization in each of groups 1–5, PBMCs were collected and tested for GRI...
Magnitude of IFN-γ ELISPOT response (SFC/106 PBMC) and responder rate (%)at one week post last vacci...
<p>IFN-γ ELISpot to (A) Gag and (B) the Env peptide pool after the second HIV-MVA, at the time of fi...
(A) the DNA vaccine-specific Gag Smi peptide pool and, (B) the HIV-MVA vaccine-specific Gag CMDR, (C...
<p>The subjects were classified as responders and non responders as defined in the <a href="http://w...
<p>Average magnitude of IFN-γ ELISPOT responses in SFC/10<sup>6</sup> cells (Y-axis) at each time po...
<p>Responses at baseline (BL), 2 weeks after <i>prime (Prm)</i> and 2 weeks after boost (Bst) are sh...
<p>The y-axis shows the SFC/10<sup>6</sup> PBMC on a half-log scale and the x-axis shows the time po...
<p>The panels show individual background-subtracted IFN-γ ELISPOT counts to each antigen at 2 weeks ...
<p>Panels A and C: ELISpot activities (sfc/m) of each volunteer to CSP or AMA1 peptide pools are sho...
<p>Of 242 screened volunteers, 120 subjects were assessed eligible for enrollment, allocated to one ...
<p>In the column “Short-term response SOT” is the number of patients given that had a positive respo...
<p>Gray dots: response below the cut-off to any of the 6 peptide pools; red dots: response above the...
Ex vivo functional immunoassays such as ELISpot and intracellular cytokine staining (ICS) by flow cy...
<p>HIV-specific IFN-γ ELISpot responses two weeks after the first (upper panels) and second (lower p...
<p>At 2 weeks post final immunization in each of groups 1–5, PBMCs were collected and tested for GRI...
Magnitude of IFN-γ ELISPOT response (SFC/106 PBMC) and responder rate (%)at one week post last vacci...
<p>IFN-γ ELISpot to (A) Gag and (B) the Env peptide pool after the second HIV-MVA, at the time of fi...
(A) the DNA vaccine-specific Gag Smi peptide pool and, (B) the HIV-MVA vaccine-specific Gag CMDR, (C...
<p>The subjects were classified as responders and non responders as defined in the <a href="http://w...
<p>Average magnitude of IFN-γ ELISPOT responses in SFC/10<sup>6</sup> cells (Y-axis) at each time po...
<p>Responses at baseline (BL), 2 weeks after <i>prime (Prm)</i> and 2 weeks after boost (Bst) are sh...
<p>The y-axis shows the SFC/10<sup>6</sup> PBMC on a half-log scale and the x-axis shows the time po...
<p>The panels show individual background-subtracted IFN-γ ELISPOT counts to each antigen at 2 weeks ...
<p>Panels A and C: ELISpot activities (sfc/m) of each volunteer to CSP or AMA1 peptide pools are sho...
<p>Of 242 screened volunteers, 120 subjects were assessed eligible for enrollment, allocated to one ...
<p>In the column “Short-term response SOT” is the number of patients given that had a positive respo...
<p>Gray dots: response below the cut-off to any of the 6 peptide pools; red dots: response above the...
Ex vivo functional immunoassays such as ELISpot and intracellular cytokine staining (ICS) by flow cy...
<p>HIV-specific IFN-γ ELISpot responses two weeks after the first (upper panels) and second (lower p...